| N-ALPHA-FMOC-N-OMEGA-(2,2,4,6,7-PENTAMETHYLDIHYDRO-BENZOFURAN-5-SULFONYL)-L-ARGININE 4-BENZYLOXYBENZYL ESTER POLYMER BOUND |
| N-alpha-t-Butyloxycarbonyl-L-leucine p-nitrophenyl ester |
| 2212-75-1 | N-alpha-Cbz-L-lysine |
| 475-31-0 | Glycocholic acid |
| 61315-61-5 | BOC-D-Arg(Tos)-OH |
| 25461-00-1 | N-ALPHA-T-BOC-ETHYLMERCAPTO-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT |
| 1272755-09-5 | N-ALPHA-TRITYL-O-BENZYL-L-HOMOSERINE DIETHYLAMINE |
| 5354-94-9 | N-ALPHA-BENZOYL-L-HISTIDINE |
| 115290-74-9 | N(alpha)-((acetylthio)acetyl)-phenylalanyl-prolyl-arginine chloromethyl ketone |
| N-ALPHA-T-BUTYLOXYCARBONYL-L-HOMOTYROSINE DICYCLOHEXYLAMINE |
| 186350-56-1 | N-alpha-Allyloxycarbonyl-N-epsilon-(9-fluorenylmethyloxycarbonyl)-L-lysine |
| NALPHA-TERT-BUTOXYCARBONYL-L-TERT-LEUCINE |
| 117855-58-0 | N(alpha)-(2-naphthylsulfonylglycyl)-4-oxamidinophenylalanine piperidide |
| 109273-51-0 | N(alpha)-(2-naphthylsulfonylglycyl)-4-guanidinomethylphenylalaninepiperidide |
| 1263045-14-2 | N-alpha-t-Butyloxycarbonyl-beta-(2-benzothiazolyl)-L-alanine |
| 854890-33-8 | N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-in-t-butyloxycarbonyl-L-dihydrotryptophan |
| N-ALPHA-TERT-BUTOXYCARBONYL-L-PHENYLGLYCINE |
| N-alpha-Boxycarbonyl-L-propargylglycine |
| 10236-44-9 | N(alpha)-acetylglycyllysyl methyl ester |
| 36186-55-7 | N(alpha)-tosylarginine-4-nitroanilide |
| NALPHA-TERT-BUTOXYCARBONYL-L-ASPARTIC ACID |
| N-ALPHA-T-BUTYLOXYCARBONYL-L-3-IODO-TYROSINE |
| NALPHA-TERT-BUTOXYCARBONYL-3-(2-THIENYL)-L-ALANINE |
| Name Reactions and Reagents In Organic Synthesis |
| N(alpha)--fluorenylmethyloxycarbonylamino-4N-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)butyric acid |
| N-ALPHA-TERT-BUTYLOXYCARBONYL-(S)-AZEPIN-2-CARBOXYLIC ACID |
| N-ALPHA-TERT-BUTOXYCARBONYL-D-NORLEUCINE |
| NALPHA-TERT-BUTOXYCARBONYL-3-(4-THIAZOLYL)-D-ALANINE |
| N-alpha-Methyl-L-aspartic acid -t-butyl ester hydrochloride |
| N-alpha-t-Butyloxycarbonyl-N-gamma-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-L-2,3-diaminopropionic acid |
| N-alpha-t-Butyloxycarbonyl-gamma-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-2,4-diaminobutyric acid |
| N-alpha-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-N-gamma-(9-fluorenylmethyloxycarbonyl)-L-ornithine |
| N-alpha-t-Butyloxycarbonyl-N-beta-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-L-2,4-diaminobutyric acid |
| N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-Lys[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-OH |
| N-alpha-t-Butoxycarbonyl-L-alpha--diaminopropionic acid -alpha-methyl ester hydrochloride (Boc-Dap-methoxy hydrochloride) |
| N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-gamma[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-ornithine |
| 121505-94-0 | N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE |
| N-ALPHA-T-BUTYLOXYCARBONYL-DIPROPYLGLYCINE DICYCLOHEXYLAMINE |
| N-ALPHA-TRITYL-D-HOMOSERINE DIETHYLAMMONIUM SALT |
| N-ALPHA-T-BUTYLOXYCABONYL-N-ALPHA-METHYL-L-ISOLEUCINE |
| 70882-66-5 | N-alpha-Cbz-D-2-4-diaminobutanoic acid |
| 132388-59-1 | Fmoc-Asn(Trt)-OH |
| 104257-22-9 | N(alpha)-dansyl-N(omega)-1,N(6)-etheno-ADP-ribosylarginine methyl ester |
| 3-(3-(N-(alpha-methylbenzyl)aminomethyl)pyrrolidiny)-5-((2-oxooxazolidinyl)methyl)indole |
| 99124-74-0 | N(alpha)-acetyl-epsilon-(2-propenal)lysine |
| 3-(N-alpha-methylbenzyl)aminomethyl-1-(2-(5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl)ethyl)pyrrolidine |
| N-ALPHA-TERT-BUTOXYCARBONYL-L-PROLINOL |
| 84000-01-1 | NALPHA-9-Fluorenylmethoxycarbonyl-L-pipecolinic acid |
| N-(A-METHYL-4-NITROBENZYLIDENE)BENZYLAMINE |
| N(a)-Methylhistamine, DiHCl |
| N-[A-METHYL-4-(METHYLSULPHONYL)BENZYL]-N-(TETRAHYDROFURFURYL)BENZAMIDE |
| 105026-59-3 | N-(A-METHYLBENZYL)-1-AMINOBENZOTRIAZOLE |
| 6907-73-9 | N-(A-METHYLBENZYLIDENE)ISOPROPYLAMINE |
| 34520-00-8 | 6α-Naloxol Hydrochloride |
| Naloxone-d5 3-β-D-Glucuronide |
| 156047-22-2 | Naloxone-3-sulfate Sodium Salt |
| 6β-Naloxol-d5 Hydrochloride |
| Naloxone 2,3,4-Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester |
| Naloxol 6-b-D-glucuronide |
| 854601-70-0 | Naloxegol |
| 112242-14-5 | Naloxone N-Oxide |
| 24326-39-4 | NALOXOL-3-GLUCURONIDE |
| 465-65-6 | Naloxone |
| 1261079-38-2 | NALOXONE-D5 |
| NALOXONE-3-GLUCURONIDE |
| 50510-01-5 | Naloxone-3,14-diacetate |
| Naloxol 6--D-Glucuronide |
| 93302-47-7 | NALOXONE METHIODIDE |
| 1261082-21-6 | Naloxone-d5 3-Methyl Ether |
| NALOXONE, [N-ALLYL 2,3-3H] |
| NALOXONE HYDROCHLORIDE DIHYDRATE MM(CRM STANDARD) |
| NALOXONE IMPURITY A4,5-ALPHA-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE (NOROXYMORPHONE) EPN(CRM STANDARD) |
| NALP1 (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7) (A)
|
| 22135-79-1 | Naloxone 3-b-D-Glucuronide |
| NALOXONE HYDROCHLORIDE BP STANDARD(CRM STANDARD) |
| NALOXONE HYDROCHLORIDE ASSAY STANDARD BP(CRM STANDARD) |
| NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1) (A)
|
| NALOXONE HYDROCHLORIDE EPN(CRM STANDARD) |
| NALOXONE MM(CRM STANDARD) |
| NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1)
|
| 87872-71-7 | naloxone-6-spirohydantoin |
| naloxone receptor |
| 73674-85-8 | naloxazone |
| 71786-91-9 | naloxazine |
| 82824-01-9 | NALOXONAZINE DIHYDROCHLORIDE |
| NALP1, NT (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7)
|
| 119630-94-3 | NALOXONE BENZOYLHYDRAZONE |
| NALOXONE USP(CRM STANDARD) |
| naloxone-3-O-methyl-oxime |
| 88641-41-2 | NALOXONE FLUORESCEIN |
| NALOXONE BENZOYLHYDRAZONE |
| 51481-60-8 | Naloxone hydrochloride dihydrate |
| 357-08-4 | Naloxone hydrochloride |
| 126580-45-8 | Naloxyindole |
| Naloxone methylbromide |
| NALP1 protein |
| NB.BPU10I |
| NBC1 (HCO3 Cotransporters 1, pNBC) A
|
| NBC1 (HCO3 Cotransporters 1)
|
| NBC3 (HCO3 Cotransporters 3) C
|